Rheumatoid factors: clinical applications F Ingegnoli, R Castelli, R Gualtierotti Disease markers 35, 727-734, 2013 | 367 | 2013 |
Side effects of long-term prophylaxis with attenuated androgens in hereditary angioedema: comparison of treated and untreated patients M Cicardi, R Castelli, LC Zingale, A Agostoni Journal of allergy and clinical immunology 99 (2), 194-196, 1997 | 209 | 1997 |
Management of cancer-associated anemia with erythropoiesis-stimulating agents: ASCO/ASH clinical practice guideline update J Bohlius, K Bohlke, R Castelli, B Djulbegovic, MB Lustberg, M Martino, ... Blood advances 3 (8), 1197-1210, 2019 | 200 | 2019 |
Acquired deficiency of the inhibitor of the first complement component: presentation, diagnosis, course, and conventional management LC Zingale, R Castelli, A Zanichelli, M Cicardi Immunology and Allergy Clinics 26 (4), 669-690, 2006 | 159 | 2006 |
Angioedema due to acquired C1-inhibitor deficiency: a bridging condition between autoimmunity and lymphoproliferation M Cugno, R Castelli, M Cicardi Autoimmunity reviews 8 (2), 156-159, 2008 | 126 | 2008 |
The heparins and cancer: review of clinical trials and biological properties R Castelli, F Porro, P Tarsia Vascular medicine 9 (3), 205-213, 2004 | 121 | 2004 |
Syncope in patients with pulmonary embolism: comparison between patients with syncope as the presenting symptom of pulmonary embolism and patients with pulmonary embolism … R Castelli, P Tarsia, C Tantardini, G Pantaleo, AGF Porro Vascular medicine 8 (4), 257-261, 2003 | 100 | 2003 |
Lymphoproliferative disease and acquired C1 inhibitor deficiency R Castelli, DL Deliliers, LC Zingale, EM Pogliani, M Cicardi Haematologica 92 (5), 716-718, 2007 | 96 | 2007 |
Thrombosis and hemostatic abnormalities in hematological malignancies R Colombo, P Gallipoli, R Castelli Clinical Lymphoma Myeloma and Leukemia 14 (6), 441-450, 2014 | 86 | 2014 |
Acquired C1-inhibitor deficiency and lymphoproliferative disorders: a tight relationship R Castelli, A Zanichelli, M Cicardi, M Cugno Critical Reviews in Oncology/Hematology 87 (3), 323-332, 2013 | 75 | 2013 |
Reduction in transmission of hepatitis C after the introduction of a heat‐treatment step in the production of C1‐inhibitor concentrate M Cicardi, PM Mannucci, R Castelli, MG Rumi, A Agostoni Transfusion 35 (3), 209-212, 1995 | 64 | 1995 |
Thromboembolic complications in malignant haematological disorders R Castelli, B Ferrari, A Cortelezzi, A Guariglia Current Vascular Pharmacology 8 (4), 482-494, 2010 | 55 | 2010 |
Intrathoracic masses due to extramedullary hematopoiesis R Castelli, G Graziadei, M Karimi, MD Cappellini The American journal of the medical sciences 328 (5), 299-303, 2004 | 54 | 2004 |
High prevalence of splenic marginal zone lymphoma among patients with acquired C1 inhibitor deficiency R Castelli, MA Wu, M Arquati, A Zanichelli, C Suffritti, D Rossi, M Cicardi British Journal of Haematology 172 (6), 902-908, 2016 | 49 | 2016 |
The Janus faces of acquired angioedema: C1-inhibitor deficiency, lymphoproliferation and autoimmunity MA Wu, R Castelli Clinical Chemistry and Laboratory Medicine (CCLM) 54 (2), 207-214, 2016 | 47 | 2016 |
Heparin induced thrombocytopenia: pathogenetic, clinical, diagnostic and therapeutic aspects R Castelli, E Cassinerio, MD Cappellini, F Porro, G Graziadei, F Fabris Cardiovascular & Haematological Disorders-Drug Targets (Formerly Current …, 2007 | 47 | 2007 |
Effect of hydroxyurea on extramedullary haematopoiesis in thalassaemia intermedia: case reports and literature review A Meo, E Cassinerio, R Castelli, D Bignamini, L Perego, MD Cappellini International Journal of Laboratory Hematology 30 (5), 425-431, 2008 | 37 | 2008 |
Current and emerging treatment options for patients with relapsed myeloma R Castelli, R Gualtierotti, N Orofino, A Losurdo, S Gandolfi, M Cugno Clinical Medicine Insights: Oncology 7, CMO. S8014, 2013 | 34 | 2013 |
Biosimilar epoetin in elderly patients with low-risk myelodysplastic syndromes improves anemia, quality of life, and brain function R Castelli, GL Deliliers, R Colombo, G Moreo, P Gallipoli, G Pantaleo Annals of hematology 93, 1523-1529, 2014 | 33 | 2014 |
Immunomodulatory Drugs: New Options for the Treatment of Myelodysplastic Syndromes R Castelli, R Cassin, A Cannavò, M Cugno Clinical Lymphoma Myeloma and Leukemia 2013 (13), 1-7, 2013 | 33 | 2013 |